For in vitro diagnostic use. Others Elecsys SCC IVD Elecsys® SCC CPS_000511 07028253190 SCC Elecsys E2G 100 Elecsys SCC 04015630940561 Reagents, kits 100 tests cobas e 402/801 true 07126972190 SCC Elecsys cobas e 100 Elecsys SCC 04015630942619 Reagents, kits 100 tests cobas e 411/601/602 true 07028253500 Elecsys SCC en 5 FF000000049F6D0E FF0000000447950E 07028253190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of squamous cell carcinoma (SCC) antigen in human serum and plasma. The assay is used as an aid in the management of patients with squamous cell carcinoma. The results must be interpreted in conjunction with other methods in accordance with standard clinical management guidelines.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07126972500 Elecsys SCC en 6 FF0000000461D70E FF0000000146D70E 07126972190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of squamous cell carcinoma (SCC) antigen in human serum and plasma. The assay is used as an aid in the management of patients with squamous cell carcinoma. The results must be interpreted in conjunction with other methods in accordance with standard clinical management guidelines.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en